Liberty Health Sciences (LHSIF) Stock Price, News & Analysis

Company Overview

Liberty Health Sciences, trading on the OTC Markets under the symbol LHSIF, is a vertically integrated medical cannabis company headquartered in Florida. The company holds state‐issued Medical Marijuana Treatment Center licenses that authorize cultivation, processing and retail operations within Florida’s regulated medical marijuana program. Its state‐of‐the‐art cultivation facilities feature controlled indoor and greenhouse environments designed to produce consistent, high‐quality flower and derivative products.

Liberty Health Sciences markets its products under the Sunshine Cannabis Co. brand, offering a range of cannabis formulations that include dried flower, pre-rolled joints, concentrates, oils, capsules and topical preparations. The company’s product portfolio is tailored to meet the needs of medical patients who qualify under Florida’s medical cannabis framework, with proprietary cultivation protocols aimed at optimizing cannabinoid profiles and ensuring compliance with rigorous testing and safety standards.

Originally founded in 2014 as VitaCann, the business rebranded as Liberty Health Sciences in 2017 after securing its vertical license in Florida’s nascent medical marijuana market. Since then, the company has expanded its footprint through the development of additional cultivation and processing capacity as well as the opening of multiple Sunshine Cannabis Co. dispensaries across the state. Under the leadership of CEO Oliver Horn, Liberty Health Sciences continues to focus on operational execution, product innovation and patient engagement as it seeks to solidify its position in one of the largest medical cannabis markets in the United States.

Key Stats

• Today's Range: $1.10 to $1.17
• 50-Day Range: $1.14 to $1.14
• 52-Week Range: $0.23 to $1.23
• Volume: 671,400 shs
• Average Volume: 1.67 million shs
• Market Capitalization: $392.01 million
• P/E Ratio: 38.17
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LHSIF Stock Analysis - Frequently Asked Questions

How have LHSIF shares performed this year?

Liberty Health Sciences' stock was trading at $1.1446 at the beginning of the year. Since then, LHSIF stock has increased by 0.0% and is now trading at $1.1446.

How do I buy shares of Liberty Health Sciences?

Shares of LHSIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LHSIF
• CIK: N/A
• Web: www.libertyhealthsciences.com
• Phone: 833-254-4877
• Fax: N/A
• Employees: 291
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 38.17
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $16.80 million
• Net Margins: 19.34%
• Pretax Margin: N/A
• Return on Equity: 9.51%
• Return on Assets: 6.78%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.93
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: $37.77 million
• Price / Sales: 10.38
• Cash Flow: $0.04 per share
• Price / Cash Flow: 26.78
• Book Value: $0.31 per share
• Price / Book: 3.69

Miscellaneous

• Outstanding Shares: 342,490,000
• Free Float: N/A
• Market Cap: $392.01 million
• Optionable: Not Optionable
• Beta: 1.70